Found: 7
Select item for more details and to access through your institution.
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02125-5
- By:
- Publication type:
- Article
Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
- Published in:
- NAR Cancer, 2021, v. 3, n. 3, p. 1, doi. 10.1093/narcan/zcab028
- By:
- Publication type:
- Article
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization.
- Published in:
- Journal of Cell Biology, 2011, v. 194, n. 1, p. 39, doi. 10.1083/jcb.201102027
- By:
- Publication type:
- Article
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization.
- Published in:
- Journal of Cell Biology, 2011, v. 193, n. 8, p. 39, doi. 10.1083/jcb.201102027
- By:
- Publication type:
- Article
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 11, p. 1, doi. 10.1038/s41419-021-04262-x
- By:
- Publication type:
- Article
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance.
- Published in:
- Nucleic Acids Research, 2023, v. 51, n. 20, p. 11056, doi. 10.1093/nar/gkad791
- By:
- Publication type:
- Article
Characterization of an alternative BAK-binding site for BH3 peptides.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17074-y
- By:
- Publication type:
- Article